Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-17 10:15 am Purchase | 2023-03-09 | 13G | Embark Technology, Inc. EMBK | BML Investment Partners, L.P. | 994,355 5.200% | 994,355 (New Position) | Filing History |
| 2023-02-08 5:29 pm Sale | 2023-02-08 | 13G | Astrotech Corporation ASTC | BML Investment Partners, L.P. | 232,065 13.700% | -5,247,257 (-95.76%) | Filing History |
| 2023-02-08 5:24 pm Unchanged | 2023-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN | BML Investment Partners, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-08 5:23 pm Sale | 2023-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN | BML Investment Partners, L.P. | 0 0.000% | -1,764,274 (Position Closed) | Filing History |
| 2023-02-08 5:09 pm Unchanged | 2023-02-08 | 13G | Pardes Biosciences, Inc. PRDS | BML Investment Partners, L.P. | 4,867,984 7.800% | 0 (Unchanged) | Filing History |
| 2023-02-08 5:06 pm Unchanged | 2023-02-08 | 13G | Graybug Vision, Inc. GRAY | BML Investment Partners, L.P. | 88,282 5.700% | 0 (Unchanged) | Filing History |
| 2023-02-08 4:55 pm Purchase | 2023-02-08 | 13G | Satsuma Pharmaceuticals, Inc. STSA | BML Investment Partners, L.P. | 6,590,000 19.900% | 150,000 (+2.33%) | Filing History |
| 2023-02-08 4:44 pm Purchase | 2023-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM | BML Investment Partners, L.P. | 730,018 7.300% | 212,468 (+41.05%) | Filing History |
| 2023-02-08 4:35 pm Purchase | 2023-02-08 | 13G | Climb Bio, Inc. CLYM | BML Investment Partners, L.P. | 1,897,614 7.100% | 158,236 (+9.10%) | Filing History |
| 2023-02-08 4:16 pm Purchase | 2023-02-08 | 13G | Bitwise MARA Option Income Strategy ETF IMRA | BML Investment Partners, L.P. | 834,444 12.700% | 39,444 (+4.96%) | Filing History |
| 2023-02-08 4:02 pm Purchase | 2023-02-08 | 13G | Astrotech Corporation ASTC | BML Investment Partners, L.P. | 5,479,322 13.700% | 5,479,322 (New Position) | Filing History |
| 2023-02-08 3:43 pm Purchase | 2023-02-08 | 13G | Metacrine, Inc. MTCR | BML Investment Partners, L.P. | 6,767,458 15.900% | 278,493 (+4.29%) | Filing History |
| 2023-02-08 3:23 pm Purchase | 2023-02-08 | 13G | Tilly's, Inc. TLYS | BML Investment Partners, L.P. | 1,234,844 5.500% | 80,000 (+6.93%) | Filing History |
| 2023-02-08 3:05 pm Sale | 2023-02-08 | 13G | Richardson Electronics, Ltd. RELL | BML Investment Partners, L.P. | 95,359 0.800% | -614,641 (-86.57%) | Filing History |
| 2023-02-08 2:48 pm Purchase | 2023-02-08 | 13G | ARCA biopharma, Inc. ABIO | BML Investment Partners, L.P. | 71,521 5.950% | 8,033 (+12.65%) | Filing History |
| 2023-02-08 2:38 pm Sale | 2023-02-08 | 13G | Retractable Technologies, Inc. RVP | BML Investment Partners, L.P. | 1,056,075 3.200% | -2,681,425 (-71.74%) | Filing History |
| 2023-02-02 4:23 pm Purchase | 2023-01-24 | 13G | Surrozen, Inc. SRZN | BML Investment Partners, L.P. | 111,269 5.600% | 111,269 (New Position) | Filing History |
| 2023-01-26 4:01 pm Purchase | 2023-01-20 | 13G | CYTEIR THERAPEUTICS INC CYTT | BML Investment Partners, L.P. | 2,735,973 7.700% | 2,735,973 (New Position) | Filing History |
| 2023-01-09 12:28 pm Purchase | 2022-12-29 | 13G | Disc Medicine, Inc. IRON | BML Investment Partners, L.P. | 524,750 3.100% | 524,750 (New Position) | Filing History |
| 2022-12-30 5:30 pm Purchase | 2022-12-21 | 13G | Pardes Biosciences, Inc. PRDS | BML Investment Partners, L.P. | 4,867,984 7.800% | 4,867,984 (New Position) | Filing History |